Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Acadia Pharmaceuticals

Tracked across 4 events · 25 articles · First seen Jun 16, 2026 · Last active Sep 15, 2026

Sentiment
35
Attention
6
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 70
Regulatory
Impact: Acadia Pharmaceuticals Inc. received a positive opinion from the CHMP for DAYBU, which could lead to its approval in the EU, significantly boosting the company's market position and revenue potential.
Jun 26, 2026 · 6 articles
4 70
Regulatory
Impact: Acadia is the developer and marketer of DAYBU. The EU approval expands its market and strengthens its rare disease franchise, supporting its long-term growth targets.
Aug 24, 2026 · 7 articles
1 0
Business
Impact: Acadia Pharmaceuticals is mentioned as Ridloff's former employer, where she raised $600 million in capital.
Aug 10, 2026 · 6 articles
1 0
Accidents
Two 24-year-old friends, Malaika Chitre of Dayton, New Jersey, and Navam Kaul of Sayreville, New Jersey, were fatally struck by a southbound No. 4 train at the Spring Street subway station in Lower Manhattan in…
Impact: One of the two victims, Malaika Chitre, worked as an operations specialist at Acadia Pharmaceuticals; the company faces no operational or financial impact from the accident.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Acadia Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.